Instead of a central catheter, the study suggests using a peripheral catheter for continuous intravenous infusion of hypertonic saline. This would cut down on unnecessary use of central catheters, which would lower costs and could lead to fewer infections.
Researchers conducted a retrospective study at two academic medical centers of data on patients treated with continuous intravenous infusion of the solution. Of the 213 patients who had the solution administered peripherally, 15 had infusion-related reactions. Most (73.7 percent) received their entire treatment peripherally.
“Current recommendations that a central catheter is required for continuous intravenous infusion of 3 percent sodium chloride solution should be re-evaluated,” the study concludes. “Only a few patients who had peripheral infusions had infusion-related reactions.”
More articles on patient safety:
769 hospitals see Medicare payments cut over high HAC rates: 7 things to know
AACN issues practice alerts on CAUTIs, VTE and delirium
Manuka honey could boost CAUTI prevention
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.